Ultrastructural evaluation of cell death following CB1954 treatment off cancer cells expressing nitroreductase.

被引：0
|
作者：
Brown, G [1 ]
Beesley, JE [1 ]
Court, S [1 ]
Ford, M [1 ]
机构：
[1] Glaxo Wellcome Res & Dev Ltd, Mol Pathol Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England
来源：
ELECTRON MICROSCOPY 1998, VOL 4: BIOLOGICAL SCIENCES | 1998年
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：813 / 814
页数：2
相关论文
共 16 条
  • [1] Gene therapy for pancreatic cancer: In vivo killing of tumour cells expressing E-coli nitroreductase following administration of the prodrug CB1954
    Green, NK
    Youngs, DJ
    Young, LS
    Kerr, DJ
    Neoptolemos, JP
    Searle, PF
    GUT, 1997, 41 : A188 - A188
  • [2] A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1954
    Patel, Prashant
    Young, J. Graham
    Mautner, Vivien
    Ashdown, Daniel
    Bonney, Sarah
    Pineda, Robert G.
    Collins, Stuart I.
    Searle, Peter F.
    Hull, Diana
    Peers, Elizabeth
    Chester, John
    Wallace, D. Michael
    Doherty, Alan
    Leung, Hing
    Young, Lawrence S.
    James, Nicholas D.
    MOLECULAR THERAPY, 2009, 17 (07) : 1292 - 1299
  • [3] Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954
    Lukashev, AN
    Fuerer, C
    Chen, MJ
    Searle, P
    Iggo, R
    HUMAN GENE THERAPY, 2005, 16 (12) : 1473 - 1483
  • [4] Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954
    Jane A Plumb
    Alan Bilsland
    Rania Kakani
    Jiangqin Zhao
    Rosalind M Glasspool
    Richard J Knox
    T R Jeffry Evans
    W Nicol Keith
    Oncogene, 2001, 20 : 7797 - 7803
  • [5] Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954
    Plumb, JA
    Bilsland, A
    Kakani, R
    Zhao, JQ
    Glasspool, RM
    Knox, RJ
    Evans, TRJ
    Keith, WN
    ONCOGENE, 2001, 20 (53) : 7797 - 7803
  • [6] Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E-coli nitroreductase gene
    Searle, PF
    Weedon, SJ
    McNeish, IA
    Gilligan, MG
    Ford, MJ
    Friedlos, F
    Springer, CJ
    Young, LS
    Kerr, DJ
    GENE THERAPY OF CANCER, 1998, 451 : 107 - 113
  • [7] Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E-coli nitroreductase gene
    Searle, PF
    Weedon, SJ
    McNeish, I
    Gilligan, MG
    Ford, MJ
    Friedlos, F
    Springer, CJ
    Young, LS
    Kerr, DJ
    CANCER GENE THERAPY, 1997, 4 (05) : 304 - 304
  • [8] Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
    D H Palmer
    A E Milner
    D J Kerr
    L S Young
    British Journal of Cancer, 2003, 89 : 944 - 950
  • [9] Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase
    Friedlos, F
    Court, S
    Ford, M
    Denny, WA
    Springer, C
    GENE THERAPY, 1998, 5 (01) : 105 - 112
  • [10] Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
    Palmer, DH
    Milner, AE
    Kerr, DJ
    Young, LS
    BRITISH JOURNAL OF CANCER, 2003, 89 (05) : 944 - 950
12